Related Experiment Video
Updated: Apr 19, 2026

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
Tumor volume: an adjunct prognostic factor in cutaneous melanoma
Robert G Walton, Jinah Kim, Cruz Velasco
1Department of Dermatology/Cutaneous Oncology, Stanford University Medical Center and Cancer Institute, 900 Blake Wilbur Dr, W3045, Stanford, CA 94305-5356, USA. sswetter@stanford.edu.
Tumor volume measurement, calculated from lesion surface area and Breslow depth, may predict sentinel lymph node metastasis in cutaneous melanoma. This prognostic factor could aid in assessing risk for both thin and thick melanomas.
Area of Science:
- Oncology
- Dermatology
- Pathology
Background:
- Established prognostic factors for cutaneous melanoma include Breslow depth, ulceration, mitotic index, lymphovascular invasion, and microsatellites.
- Tumor volume is increasingly recognized as a potential prognostic indicator in various cancers.
Purpose of the Study:
- To evaluate the utility of a 250 mm³ tumor volume cutoff, derived from surface area and Breslow depth, as a predictor of sentinel lymph node (SLN) metastasis in cutaneous melanoma.
- To investigate the relevance of tumor volume in both thin and thick invasive melanomas.
Main Methods:
- Tumor volume calculated by multiplying lesion surface area (longest vertical x horizontal measurements) by Breslow depth.
- Utilized pathology database from the institution for a larger sample size analysis.
Main Results:
- A tumor volume cutoff of 250 mm³ shows potential as a predictor for SLN metastasis.
- This metric may be relevant across different melanoma thicknesses.
Conclusions:
- Tumor volume measurement is a potentially valuable adjunct to existing prognostic factors in cutaneous melanoma.
- Further investigation with larger sample sizes supports its role in predicting SLN metastasis.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression

